Cargando…

Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease

BACKGROUND: Patients with nonalcoholic fatty liver disease (NAFLD) are highly at risk for cardiovascular disease (CVD). However, the risk of developing CVD in patients with lean NAFLD is not yet fully understood. Therefore, this study aimed to compare the CVD incidence in Japanese patients with lean...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishido, Shun, Tamaki, Nobuharu, Takahashi, Yuka, Uchihara, Naoki, Suzuki, Keito, Tanaka, Yuki, Miyamoto, Haruka, Yamada, Michiko, Matsumoto, Hiroaki, Nobusawa, Tsubasa, Keitoku, Taisei, Takaura, Kenta, Tanaka, Shohei, Maeyashiki, Chiaki, Yasui, Yutaka, Tsuchiya, Kaoru, Nakanishi, Hiroyuki, Kurosaki, Masayuki, Izumi, Namiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276489/
https://www.ncbi.nlm.nih.gov/pubmed/37330485
http://dx.doi.org/10.1186/s12876-023-02848-7
_version_ 1785060090146979840
author Ishido, Shun
Tamaki, Nobuharu
Takahashi, Yuka
Uchihara, Naoki
Suzuki, Keito
Tanaka, Yuki
Miyamoto, Haruka
Yamada, Michiko
Matsumoto, Hiroaki
Nobusawa, Tsubasa
Keitoku, Taisei
Takaura, Kenta
Tanaka, Shohei
Maeyashiki, Chiaki
Yasui, Yutaka
Tsuchiya, Kaoru
Nakanishi, Hiroyuki
Kurosaki, Masayuki
Izumi, Namiki
author_facet Ishido, Shun
Tamaki, Nobuharu
Takahashi, Yuka
Uchihara, Naoki
Suzuki, Keito
Tanaka, Yuki
Miyamoto, Haruka
Yamada, Michiko
Matsumoto, Hiroaki
Nobusawa, Tsubasa
Keitoku, Taisei
Takaura, Kenta
Tanaka, Shohei
Maeyashiki, Chiaki
Yasui, Yutaka
Tsuchiya, Kaoru
Nakanishi, Hiroyuki
Kurosaki, Masayuki
Izumi, Namiki
author_sort Ishido, Shun
collection PubMed
description BACKGROUND: Patients with nonalcoholic fatty liver disease (NAFLD) are highly at risk for cardiovascular disease (CVD). However, the risk of developing CVD in patients with lean NAFLD is not yet fully understood. Therefore, this study aimed to compare the CVD incidence in Japanese patients with lean NAFLD and those with non-lean NAFLD. METHODS: A total of 581 patients with NAFLD (219 with lean and 362 with non-lean NAFLD) were recruited. All patients underwent annual health checkups for at least 3 years, and CVD incidence was investigated during follow-up. The primary end-point was CVD incidence at 3 years. RESULTS: The 3-year new CVD incidence rates in patients with lean and non-lean NAFLD were 2.3% and 3.9%, respectively, and there was no significant difference between two groups (p = 0.3). Multivariable analysis adjusted for age, sex, hypertension, diabetes, and lean NAFLD/non-lean NAFLD revealed that age (every 10 years) as an independent factor associated with CVD incidence with an odds ratio (OR) of 2.0 (95% confidence interval [CI]: 1.3–3.4), whereas lean NAFLD was not associated with CVD incidence (OR: 0.6; 95% CI: 0.2–1.9). CONCLUSIONS: CVD incidence was comparable between patients with lean NAFLD and those with non-lean NAFLD. Therefore, CVD prevention is needed even in patients with lean NAFLD.
format Online
Article
Text
id pubmed-10276489
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102764892023-06-18 Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease Ishido, Shun Tamaki, Nobuharu Takahashi, Yuka Uchihara, Naoki Suzuki, Keito Tanaka, Yuki Miyamoto, Haruka Yamada, Michiko Matsumoto, Hiroaki Nobusawa, Tsubasa Keitoku, Taisei Takaura, Kenta Tanaka, Shohei Maeyashiki, Chiaki Yasui, Yutaka Tsuchiya, Kaoru Nakanishi, Hiroyuki Kurosaki, Masayuki Izumi, Namiki BMC Gastroenterol Research BACKGROUND: Patients with nonalcoholic fatty liver disease (NAFLD) are highly at risk for cardiovascular disease (CVD). However, the risk of developing CVD in patients with lean NAFLD is not yet fully understood. Therefore, this study aimed to compare the CVD incidence in Japanese patients with lean NAFLD and those with non-lean NAFLD. METHODS: A total of 581 patients with NAFLD (219 with lean and 362 with non-lean NAFLD) were recruited. All patients underwent annual health checkups for at least 3 years, and CVD incidence was investigated during follow-up. The primary end-point was CVD incidence at 3 years. RESULTS: The 3-year new CVD incidence rates in patients with lean and non-lean NAFLD were 2.3% and 3.9%, respectively, and there was no significant difference between two groups (p = 0.3). Multivariable analysis adjusted for age, sex, hypertension, diabetes, and lean NAFLD/non-lean NAFLD revealed that age (every 10 years) as an independent factor associated with CVD incidence with an odds ratio (OR) of 2.0 (95% confidence interval [CI]: 1.3–3.4), whereas lean NAFLD was not associated with CVD incidence (OR: 0.6; 95% CI: 0.2–1.9). CONCLUSIONS: CVD incidence was comparable between patients with lean NAFLD and those with non-lean NAFLD. Therefore, CVD prevention is needed even in patients with lean NAFLD. BioMed Central 2023-06-17 /pmc/articles/PMC10276489/ /pubmed/37330485 http://dx.doi.org/10.1186/s12876-023-02848-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ishido, Shun
Tamaki, Nobuharu
Takahashi, Yuka
Uchihara, Naoki
Suzuki, Keito
Tanaka, Yuki
Miyamoto, Haruka
Yamada, Michiko
Matsumoto, Hiroaki
Nobusawa, Tsubasa
Keitoku, Taisei
Takaura, Kenta
Tanaka, Shohei
Maeyashiki, Chiaki
Yasui, Yutaka
Tsuchiya, Kaoru
Nakanishi, Hiroyuki
Kurosaki, Masayuki
Izumi, Namiki
Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease
title Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease
title_full Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease
title_fullStr Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease
title_full_unstemmed Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease
title_short Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease
title_sort risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276489/
https://www.ncbi.nlm.nih.gov/pubmed/37330485
http://dx.doi.org/10.1186/s12876-023-02848-7
work_keys_str_mv AT ishidoshun riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease
AT tamakinobuharu riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease
AT takahashiyuka riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease
AT uchiharanaoki riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease
AT suzukikeito riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease
AT tanakayuki riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease
AT miyamotoharuka riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease
AT yamadamichiko riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease
AT matsumotohiroaki riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease
AT nobusawatsubasa riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease
AT keitokutaisei riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease
AT takaurakenta riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease
AT tanakashohei riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease
AT maeyashikichiaki riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease
AT yasuiyutaka riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease
AT tsuchiyakaoru riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease
AT nakanishihiroyuki riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease
AT kurosakimasayuki riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease
AT izuminamiki riskofcardiovasculardiseaseinleanpatientswithnonalcoholicfattyliverdisease